Search - tctmd.com

Displaying 21 - 31 of 31

Sort: Relevancy | Date

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Industry News

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

May 21, 2013

News Industry News

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

March 09, 2013

News Industry News

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

February 14, 2013

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Industry News

Hydration Based on Ventricular Pressure is Effective in Reducing Kidney Damage in Patients Undergoing Cardiac Catheterization

October 25, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

News Industry News

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

May 16, 2012

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

Advertisement

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Hydration Based on Ventricular Pressure is Effective in Reducing Kidney Damage in Patients Undergoing Cardiac Catheterization

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

Medtronic Starts Landmark Study of Hypertension Treatment

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content